Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Replacement of Antiretroviral Therapy with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer

AIDS Research and Human Retroviruses(2023)10.1089/aid.2022.0181Source: DataRank Database

Replacement of Antiretroviral Therapy with HIV Broadly Neutralizing Antibodies to Maximize the Effectiveness of Chemotherapy in HIV Patients with Lung Cancer is a research paper published in AIDS Research and Human Retroviruses (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: greenTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Abdolrahim Abassi,Mohammad M. Sajadi,Zahra Rikhtegaran Tehrani ORCID,Nhut Le ORCID,Hegang H. Chen

Live enrichment

PubMed:37053110 PMC:PMC10510690 OpenAlex:https://openalex.org/W4365444358

NIAID NIH HHS

Grant: R01 AI155150

NCI NIH HHS

Grant: P30 CA134274

NCI NIH HHS

Grant: R01 CA233441

BLRD VA

Grant: I01 BX004525

NIAID NIH HHS

Grant: R01 AI147870

NIAID NIH HHS

Grant: P01 AI162242

FWCI

0.00

Citation Percentile

0.3%

greenLicense: https://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10510690/pdf/aid.2022.0181.pdf

publisherhttps://www.liebertpub.com/doi/full-xml/10.1089/aid.2022.0181

publisherhttps://www.liebertpub.com/doi/pdf/10.1089/aid.2022.0181

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10510690

Fields of Study

Viral-associated cancers and disordersHIV Research and TreatmentHIV/AIDS drug development and treatment

MeSH Terms

Broadly Neutralizing AntibodiesAnimalsCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsHIV AntibodiesHIV-1HIV InfectionsMiceAntibodies, Neutralizing

Keywords

ConcomitantGemcitabineMedicineLung cancerCombination therapyCancerChemotherapyPharmacologyOncologyInternal medicineImmunologyHIVArtAnimal ModelsHiv Broadly Neutralizing Antibodies

Sustainable Development Goals

SDG 0: Good health and well-being